Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Full Text
Cardiovascular Diabetology,

Mallat SG – Clinical studies suggest that in CV high–risk patients and those with evidence of renal disease, the use of an ARB/CCB combination may be preferred to ARB/HCTZ combinations due to superior renoprotective and CV benefits and reduced metabolic side effects in patients with concomitant metabolic disorders. However, selection of the most appropriate antihypertensive combination should be dependent on careful review of the individual patient and appropriate consideration of drug pharmacology.

  • Hypertension is a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular (CV) events, comorbid diabetes mellitus, microalbuminuria and renal impairment.
  • Given that most patients with hypertension require at least two antihypertensives to achieve blood pressure (BP) goals, identifying the most appropriate combination regimen based on individual risk factors and comorbidities is important for risk management.
  • Single–pill combinations (SPCs) containing two or more antihypertensive agents with complementary mechanisms of action offer potential advantages over free–drug combinations, including simplification of treatment regimens, convenience and reduced costs.
  • The improved adherence and convenience resulting from SPC use is recognised in updated hypertension guidelines.
  • Despite a wide choice of SPCs for hypertension treatment, clinical evidence from direct head–to–head comparisons to guide selection for individual patients is lacking.
  • However, in patients with evidence of renal disease or at greater risk of developing renal disease, such as those with diabetes mellitus, microalbuminuria and high–normal BP or overt hypertension, guidelines recommend renin–angiotensin system (RAS) blocker–based combination therapy due to superior renoprotective effects compared with other antihypertensive classes.
  • Furthermore, RAS inhibitors attenuate the oedema and renal hyperfiltration associated with calcium channel blocker (CCB) monotherapy, making them a good choice for combination therapy.
  • The occurrence of angiotensin–converting enzyme (ACE) inhibitor–induced cough supports the use of angiotensin II receptor blockers (ARBs) for RAS blockade rather than ACE inhibitors.
  • In this regard, ARB–based SPCs are available in combination with the diuretic, hydrochlorothiazide (HCTZ) or the calcium CCB, amlodipine.
  • Telmisartan, a long–acting ARB with preferential pharmacodynamic profile compared with several other ARBs, and the only ARB with an indication for the prevention of CV disease progression, is available in two SPC formulations, telmisartan/HCTZ and telmisartan/amlodipine.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Ophthalmology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Ophthalmology Articles

1 Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications Full Text Therapeutics and Clinical Risk Management, September 10, 2014    Free full text    Clinical Article

2 Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology, August 4, 2014    Clinical Article

3 Femtosecond laser versus manual clear corneal incision in cataract surgery Journal of Refractive Surgery, September 2, 2014    Clinical Article

4 Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: Effect on macular swelling after cataract surgery Journal of Cataract & Refractive Surgery, September 8, 2014    Clinical Article

5 Closure technique for leaking wound resulting from thermal injury during phacoemulsification Journal of Cataract & Refractive Surgery, September 4, 2014    Clinical Article

6 Spectral domain optical coherence tomography in the diagnosis and management of glaucoma Ophthalmic Surgery, Lasers and Imaging, September 11, 2014    Clinical Article

7 Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: Systematic review of effectiveness and cost-effectiveness Full Text Clinical Ophthalmology, August 27, 2014    Free full text    Review Article

8 Canadian ophthalmologists' opinions concerning complementary and alternative medicine (CAM) use in glaucoma Journal of Glaucoma, September 12, 2014    Clinical Article

9 Novel screening method for glaucomatous eyes with myopic tilted discs: The crescent moon sign JAMA Ophthalmology, September 8, 2014    Clinical Article

10 Technique for removal of malpositioned Ex-PRESS glaucoma device Journal of Glaucoma, September 15, 2014    Clinical Article

11 Effect of 3 years of treatment with a dorzolamide/timolol (1%/0.5%) combination on intraocular pressure Full Text Clinical Ophthalmology, September 24, 2014    Free full text    Clinical Article

12 Large capsulorhexis with implantation of a 7.0 mm optic intraocular lens during cataract surgery in patients with diabetes mellitus Journal of Cataract & Refractive Surgery, September 25, 2014    Clinical Article

13 Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: A randomized clinical trial Journal of Glaucoma, September 19, 2014    Clinical Article

14 New technologies and drugs in the management of diabetic retinopathy Practical Diabetes, September 19, 2014    Clinical Article

15 Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients Full Text Drug Design, Development and Therapy, September 22, 2014    Free full text    Clinical Article

16 Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes Ophthalmology, August 8, 2014    Evidence Based Medicine    Clinical Article

17 Sunlight exposure, pigmentation, and incident age-related macular degeneration Investigative Ophthalmology & Visual Science, September 3, 2014    Clinical Article

18 Gold weight implants for management of thyroid-related upper eyelid retraction Ophthalmic Plastic and Reconstructive Surgery, September 16, 2014    Clinical Article

19 Oral azithromycin versus doxycycline in meibomian gland dysfunction: A randomized double masked open label clinical trial British Journal of Ophthalmology, September 12, 2014    Clinical Article
Exclusive Author Commentary

20 Refractive lenticule extraction: Transition and comparison of 3 surgical techniques Journal of Cataract & Refractive Surgery, September 3, 2014    Clinical Article

Indexed Journals in Ophthalmology: American Journal of Ophthalmology, Retina, Eye, Corneamore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close